Bumetanide

Bumetanide · BUMETANIDE .25 mg/mL · Injection · Intramuscular; Intravenous · Novadoz Pharmaceuticals LLC

NDC 72205-0102-07 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Medicare Part B pays (ASP+6%)$0.4980per billing unit (0.5 MG)HCPCS J1939 · Jul 1, 2026
Part D plans paid (avg)$0.4344per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$30.00

Reported to Texas DSHS · 2026 annual filing · Novadoz Pharmaceuticals, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 0.5 MG

$0.498

HCPCS J1939 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$201

12 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Msn Laboratories Private LimitedIndia
analysis · manufacture

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $32.71 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA215364
TE code: AP
Approval date: Aug 4, 2022
Patents / exclusivity: None on file

Shortage history

In shortage now — Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04)Jan 31, 2018
month 104 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)Jan 31, 2018
month 104 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bumetanide (Injection)

Labeler	Strength	First seen	Last seen
Bryant Ranch Prepack	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Camber Pharmaceuticals, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Cardinal Health 107, LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Gland Pharma Limited	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Mullan Pharmaceutical Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Novadoz Pharmaceuticals LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirst	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
Lupin Pharmaceuticals, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
Civica, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 31, 2026
Glenmark Pharmaceuticals Inc., Usa	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 31, 2026
Qilu Pharmaceutical Co., Ltd.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bumetanide — NDC 72205-0102-07," retrieved September 3, 2026, https://drugdashboards.com/drug/72205010207.

Free to cite with attribution — see how the data is put together.